Target intelligence / Profile preview

Endoplasmic reticulum membrane protein complex subunit 7 (EMC7)

Target
EMC7
Molecular classification
Other (subunit of multiprotein complex), Membrane-associated protein, Chaperone-associated complex subunit
01

Overview

Endoplasmic reticulum membrane protein complex subunit 7 (EMC7) is a subunit of the endoplasmic reticulum membrane protein complex (EMC), a multiprotein assembly that facilitates the energy-independent insertion of transmembrane domains (TMDs) into the ER membrane[2][3][1][5][4]. EMC7 forms part of the lumenal module of the EMC together with other subunits, and while it has no enzymatic activity or ligand-binding properties itself, it is crucial for the structural integrity and function of the entire EMC complex. This includes enabling the insertion and accurate folding of tail-anchored membrane proteins and multi-pass integral membrane proteins—many of which are critical for cell signaling and organelle function. Defects in EMC activity, including EMC7, are associated with impaired membrane protein biogenesis and can contribute to various disease states. However, EMC7 itself is not directly addressed as a therapeutic target, nor are drugs known to specifically target EMC7 function[2][3][4][1][5].

Other names
EMC7C11orf3C15orf24HT022UNQ905/PRO1926ORF1-FL1UPF0480 protein C15orf24Chromosome 15 hypothetical ATG/GTP binding protein
02

Mechanism of action

Not directly targeted by drugs and thus no defined mechanism for direct pharmacological action.

03

Biological functions

Assists in co- and post-translational insertion of transmembrane domains into the endoplasmic reticulum (ER) membrane[2][3][4][5][1].Maintains accurate topology and proper folding of multi-pass integral membrane proteins and tail-anchored proteins in the ER[1][3][4][5].Indirectly influences membrane protein and phospholipid biosynthesis, protein quality control, and viral replication[1][4].
04

Disease associations

Nodular hidradenomaCerebellar atrophy, visual impairment, and psychomotor retardation[3]Other (associated through malfunction of the entire EMC complex, not EMC7 alone)
05

Safety considerations

None established; gene deletion or mutation may result in protein biogenesis defects and may contribute to cellular stress and disease phenotypes, but EMC7 is not a therapeutic target[4][5][1][3].

Beyond the preview

Go deeper on Endoplasmic reticulum membrane protein complex subunit 7 (EMC7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum membrane protein complex subunit 7 (EMC7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call